- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01138449
Efficacy of Newborn Vitamin A Supplementation Versus Placebo in Improving Child Survival (NeoVitA Trial)
Efficacy of Neonatal Vitamin A Supplementation in Improving Child Survival in Haryana, India: Generation of Evidence Necessary for Informing Global Policy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study is an individually randomized trial conducted in two districts in the state of Haryana.
Community informants report births to the enrolment team. At enrolment, the team explains the study to the family and in those willing, written consent is obtained from the parents of the infant. The infant is given the dose of vitamin A/placebo and a form containing baseline socioeconomic characteristics and information on feeding practices of the infant and mother is filled.
After enrollment, each infant is visited by the enrollment team at hospital or home 1 day and 3 days after supplementation to document any illnesses in the baby. Newborns with illnesses are referred/escorted to the nearest health facility for management.
Enrolled infants are visited when aged 29 days, 3, 6 and 12 months to document vital status and hospitalizations since the last visit. Information on feeding practices, immunization, maternal intake of vitamin A rich foods and supplements, and intake of any supplement containing vitamin A by the infant is recorded at these visits. Subgroup analyses includes the effect of vitamin A supplementation in LBW and non LBW infants, male and female infants, immunized and unimmunized infants, infants of families in the poorest and richest quintiles and by vitamin A intake of mothers. For all deaths, verbal autopsy interviews are conducted.
Blood specimens are obtained in a subsample of infants at 2 weeks and 3 months of age and in a subsample of mothers at 3 months of age.
Quality control activities include independent and supervised checks and are conducted for a subsample by a separate team.
A DSMB has been constituted for the study. All deaths occurring within 72 hours of supplementation will be reported to the SAS ERC and to the WHO Coordinating Unit.
At the recent DSMB meeting in February 2012, the DSMB recommended an increase in sample size to 45,000 instead of the earlier estimate of 40,200 because of somewhat lower than expected mortality rates. This increase in sample size is expected to preserve the specified power of 0.85 and the corresponding level of precision anticipated at the design stage.
Similar trials are being funded by the World Health Organization (Geneva) in Ghana and Tanzania.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Delhi
-
New Delhi, Delhi, India, 110016
- Society for Applied Studies
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Consent to participate
- All births in the study area that are contacted by enrolment team within the eligible age window
Exclusion Criteria:
- Unable to feed on offering feeds, as reported by the mother
- Mother does not intend to stay in the study area for at least 6 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Vitamin A
Vitamin A capsules have retinol palmitate (50,000 IU) and minute amounts of vitamin E in soybean oil
|
Retinol palmitate (50,000 IU) and minute amounts of vitamin E in soybean oil, orally as a single dose to neonates on the day of birth or in the next 2 days of birth keeping a minimum period of 2 hours between the birth and the dosing
|
Placebo Comparator: Placebo
Placebo capsules contain minute amounts of vitamin E in soybean oil
|
Retinol palmitate (50,000 IU) and minute amounts of vitamin E in soybean oil, orally as a single dose to neonates on the day of birth or in the next 2 days of birth keeping a minimum period of 2 hours between the birth and the dosing
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Risk of death
Time Frame: Period between receiving the intervention/placebo and six months of age
|
To determine if vitamin A supplementation (50,000 IU) given to neonates once orally either on the day of birth or in the next 2 days will reduce mortality in the first half of infancy as compared to placebo.
|
Period between receiving the intervention/placebo and six months of age
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Risk of death
Time Frame: Period between receiving the intervention/placebo and 28 days of age
|
To determine the efficacy of vitamin A supplementation (50,000 IU) given to neonates once orally either on the day of birth or in the next 2 days in reducing mortality in the neonatal period (first month of life).
|
Period between receiving the intervention/placebo and 28 days of age
|
Risk of death
Time Frame: Period between receiving the intervention/placebo and 12 months of age
|
To determine the efficacy of vitamin A supplementation (50,000 IU) given to neonates once orally either on the day of birth or in the next 2 days in reducing mortality at 12 months.
|
Period between receiving the intervention/placebo and 12 months of age
|
Risk of hospital admission
Time Frame: Period between receiving the intervention/placebo and six months of age
|
To determine the efficacy of the above intervention in reducing the incidence of severe morbidity defined as hospitalizations due to any illness in the first 6 months of infancy.
|
Period between receiving the intervention/placebo and six months of age
|
Bulging fontanelle, vomiting, irritability, fever, diarrhea, inability to suck or feed, convulsions or any other conditions that caused parents to be concerned
Time Frame: Three day period following supplementation
|
To assess bulging fontanelle, vomiting, irritability, fever, diarrhea, inability to suck or feed, convulsions or any other conditions that caused parents to be concerned, in the 3 day period following administration of the supplement
|
Three day period following supplementation
|
Vitamin A status in a subgroup of newborns and caregivers in the intervention and placebo groups
Time Frame: Two weeks and three months of age
|
To determine vitamin A status in a subsample of infants and caregivers in the intervention and placebo groups at 2 weeks and 3 months of age in the vitamin A supplementation and placebo groups
|
Two weeks and three months of age
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Nita Bhandari, MD, PhD, Society for Applied Studies
- Principal Investigator: Sunita Taneja, MD, PhD, Society for Applied Studies
- Principal Investigator: Sarmila Mazumder, MD, PhD, Society for Applied Studies
Publications and helpful links
General Publications
- NEOVITA Study Author Group, Bahl R, Bhandari N, Dube B, Edmond K, Fawzi W, Fontaine O, Kaur J, Kirkwood BR, Martines J, Masanja H, Mazumder S, Msham S, Newton S, Oleary M, Ruben J, Shannon C, Smith E, Taneja S, Yoshida S. Efficacy of early neonatal vitamin A supplementation in reducing mortality during infancy in Ghana, India and Tanzania: study protocol for a randomized controlled trial. Trials. 2012 Feb 23;13:22. doi: 10.1186/1745-6215-13-22.
- Mazumder S, Taneja S, Bhatia K, Yoshida S, Kaur J, Dube B, Toteja GS, Bahl R, Fontaine O, Martines J, Bhandari N; Neovita India Study Group. Efficacy of early neonatal supplementation with vitamin A to reduce mortality in infancy in Haryana, India (Neovita): a randomised, double-blind, placebo-controlled trial. Lancet. 2015 Apr 4;385(9975):1333-42. doi: 10.1016/S0140-6736(14)60891-6. Epub 2014 Dec 11.
- Upadhyay RP, Martines JC, Taneja S, Mazumder S, Bahl R, Bhandari N, Dalpath S, Bhan MK. Risk of postneonatal mortality, hospitalisation and suboptimal breast feeding practices in low birthweight infants from rural Haryana, India: findings from a secondary data analysis. BMJ Open. 2018 Jun 22;8(6):e020384. doi: 10.1136/bmjopen-2017-020384.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RPC356
- UTRN 112336978-06032010834860 (Registry Identifier: Clinical Trial Registry-India)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neonatal Vitamin A Supplementation
-
King's College LondonVitamax Wholesalers LLPRecruiting
-
Boston Children's HospitalCompleted
-
Helsinki University Central HospitalUniversity of HelsinkiCompleted
-
Rajavithi HospitalCompletedPregnancy Outcome Among Vitamin D Supplementation During PregnancyThailand
-
University of AarhusNot yet recruitingImmune System Diseases | Growth | Child Development | Vitamin D Supplementation
-
Guy's and St Thomas' NHS Foundation TrustCompletedCritical Illness | Nutrition | Vitamin SupplementationUnited Kingdom
-
Cheikh Anta Diop University, SenegalInternational Atomic Energy AgencyNot yet recruiting
-
Meir Medical CenterUnknownMaternal Vitamin D Status | Neonatal Bone Quantitative Ultrasound MeasurementsIsrael
-
University of Wisconsin, MadisonCompleted
-
Institute of Nutrition of Central America and PanamaBill and Melinda Gates Foundation; Newcastle University; International Atomic...Completed
Clinical Trials on Vitamin A
-
Ohio State University Comprehensive Cancer CenterRecruitingAllogeneic Hematopoietic Stem Cell Transplantation RecipientUnited States
-
Institut de Recherche pour le DeveloppementUniversity of Copenhagen; Thrasher Research Fund; National Institute of Nutrition...CompletedMaking Maternal Post-partum Vitamin A Supplementation Effective: The Role of Timing and InflammationHealthy Women Giving Birth to Singleton InfantsVietnam
-
Sheba Medical CenterNot yet recruitingThe Relationship Between Oral Vitamin A Administration and the Incidence of BPD in Preterm Infants Born Before Week 29 of Pregnancy
-
Shiraz University of Medical SciencesNot yet recruiting
-
University GhentFlemish Interuniversity Council (VLIR); Arba Minch University, EthiopiaCompletedVitamin A Deficiency | Anemia, Iron Deficiency | Cognitive Development | Helminthic InfectionEthiopia
-
Tehran University of Medical SciencesUnknownAtherosclerosisIran, Islamic Republic of
-
Instituto Materno Infantil Prof. Fernando FigueiraCompletedVitamin A Deficiency | HypovitaminosisBrazil
-
Eunice Kennedy Shriver National Institute of Child...Unknown
-
National Food Technology Research Centre, BotswanaNetherlands: Ministry of Health, Welfare and Sports; UNICEF; University of BotswanaUnknownAssessment of Vitamin A Status of Children
-
Medical Research Council, South AfricaUniversity of Wisconsin, Madison; International Atomic Energy AgencyCompletedHypervitaminosis ASouth Africa